Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ignace DeMeyer"'
Publikováno v:
Acta clinica Belgica. 77(2)
Case Report: A 12-year-old boy, of Congolese roots and without medical history, first presented to our Emergency Department 3 days after blunt trauma of the left ankle. The boy represented on two more occasions in the next 3 days due to ongoing pain.
Publikováno v:
Open Journal of Medical Microbiology. :84-90
Micafungin is an efficacious and well-tolerated echinocandin with in vitro and in vivo activity against a broad range of Candida species. The objective of this randomized, double-blind study was to examine the pharmacokinetic parameters of micafungin
Autor:
Nicholas Amlot, Jonathan Cohen, Jean Louis Vincent, Naoki Aikawa, Kouji Mouri, Masayuki Ii, Arthur P. Wheeler, Ignace Demeyer, Stephen Sainati, Gordon R. Bernard, Derek C. Angus, Charlie Cao, Hideyasu Matsuda, Todd W. Rice
Publikováno v:
Critical Care Medicine. 38:1685-1694
Objective: To evaluate whether TAK-242, a small-molecule inhibitor of Toll-like receptor-4-mediated signaling, suppresses cytokine levels and improves 28-day all-cause mortality rates in patients with severe sepsis. Design: Randomized, double-blind,
Autor:
Marcio Nucci, D Raghunadharao, Oliver A. Cornely, Luis Ostrosky-Zeichner, Sonja Koblinger, Antonio Freire, Andrew J. Ullmann, Amorn Leelarasamee, Johan Decruyenaere, Markus Ruhnke, Ploenchan Chetchotisakd, Heike Diekmann-Berndt, Ernst-Ruediger Kuse, V Ramasubramanian, Olivier Lortholary, Jagdev Singh Sekhon, Ignace Demeyer, Clovis Arns da Cunha, Didier Pittet, Carlos H. Barrios, Frédérique Jacobs
Publikováno v:
The Lancet, Vol. 369, No 9572 (2007) pp. 1519-1527
Summary Background Invasive candidosis is increasingly prevalent in seriously ill patients. Our aim was to compare micafungin with liposomal amphotericin B for the treatment of adult patients with candidaemia or invasive candidosis. Methods We did a
Autor:
Jean-François Dhainaut, Stephen F. Lowry, Luis Jauregui, Brian Warren, Konrad Reinhart, Ignace Demeyer, John Pribble, Steven M. Opal, Thierry Dugernier, Pierre-François Laterre, Bruno François, Edward Abraham, Ángel Juan Gordo López, Xavier Wittebole, Miguel Angel Gomez Sanchez, Sonia Souza, José A. Lorente, William T. McGee, Sascha Kljucar
Publikováno v:
Critical Care Medicine. 32:332-341
Objective: Platelet-activating factor (PAF) and structurally-related oxidized phospholipids are proinflammatory mediators in systemic inflammatory states such as severe sepsis. The enzyme platelet-activating factor acetylhydrolase (PAF-AH) rapidly de
Autor:
Arthur Stanley Link, Marcus J. Zervos, Ignace DeMeyer, Hans Reinhardt Brodt, Marcelo Gareca, Christopher H. Cabell, Jack M. Bernstein, Henry F. Chambers, Donald P. Levine, Gerd Fätkenheuer, Jeffrey Parsonnet, Helen W. Boucher, Alan D. Tice, Adolf W. Karchmer, Gloria Vigliani, Vance G. Fowler, Scott G. Filler, Mark E. Rupp, Graeme N. Forrest, Paul P. Cook, Sara E. Cosgrove, Elias Abrutyn, Connie S. Price, G. Ralph Corey, Francis P. Tally, Susan J. Rehm
Publikováno v:
The New England journal of medicine. 355(7)
Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed.We randomly assigned 124 patients with S. aureus bacteremia with or without endocarditis to receive 6 mg of daptomycin intravenously per kilogram of body weight da
Autor:
M. Diefenbeck, Erwin Dhondt, Heinz Redl, Michael Beckert, Martijn van Griensven, Piotr Dziurdzik, Ulrich Schaechinger, Ansgar M. Brambrink, Jan Stroobants, Andreas Seekamp, Laura Wolowicka, Ingo Marzi, Jasmin Khan-Boluki, Jacek Gasiorowski, Stefan Rammelt, Norbert P. Haas, Ignace Demeyer, Guy Vundelinckx
Publikováno v:
Critical care medicine. 32(10)
The objectives of this study were to evaluate safety (primary) and clinical efficacy (secondary) of the humanized monoclonal anti-L-selectin antibody aselizumab in severely injured patients.Prospective phase II, parallel group, double-blind, randomiz
Autor:
Claus Peckelsen, James C. Stolzenbach, Ville Pettilä, Vincent Shu, Stuart Simon, Abla A. Creasey, Christopher J. Doig, Edward Abraham, Russell Postier, Bruce Light, Konrad Reinhart, Judy Stone, Herbert Spapen, Charles L. Sprung, Petr Svoboda, Lona Poole, Jeffrey Tobias, Sandra Percell, Steven M. Opal, Ignace Demeyer, Cathy De Deyne, Allan Seibert, Christian Zwingelstein, Antonio Artigas, Pierre-François Laterre, Angel López Rodriguez, Richard Beale
Publikováno v:
JAMA. 290(2)
Context The expression and release of tissue factor is a major trigger for the activation of coagulation in patients with sepsis. Tissue factor pathway inhibitor (TFPI) forms a complex with tissue factor and blood protease factors leading to inhibiti
Autor:
Steven Opal, Pierre-Francois Laterre, Edward Abraham, Bruno Francois, Xavier Wittebole, Stephen Lowry, Jean-Francois Dhainaut, Brian Warren, Thierry Dugernier, Angel Lopez, Miguel Sanchez, Ignace Demeyer, Luis Jauregui, Jose Angel Lorente, William McGee, Konrad Reinhart, Sascha Kljucar, Sonia Souza, John Pribble
Publikováno v:
Critical Care Medicine; Feb2004, Vol. 32 Issue 2, p332-341, 10p
Autor:
Regan, Christopher P., Morissette, Pierre, Kraus, Richard L., Wang, Erjia, Arrington, Leticia, Vavrek, Marissa, de Hoon, Jan, Depre, Marleen, Lodeweyck, Thomas, Demeyer, Ignace, Laethem, Tine, Stoch, Aubrey, Struyk, Arie
Publikováno v:
Circulation; 4/23/2024, Vol. 149 Issue 17, p1394-1396, 3p